NPSP INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of NPS Pharmaceuticals Inc. of Class Action Against the Board o...
29 Enero 2015 - 2:24PM
Levi & Korsinsky notifies investors of NPS Pharmaceuticals Inc.
("NPS Pharmaceuticals" or "the Company") (Nasdaq:NPSP) of claims of
breaches of fiduciary duty and other violations of state law
against the board of directors of the Company in connection with
the sale of the Company to Shire plc. A complaint was filed in
Delaware state court.
Click here to learn more about the action:
http://zlk.9nl.com/nps-pharmaceuticals-npsp.
Under the terms of the transaction, NPS Pharmaceuticals
shareholders will receive $46 in cash for each share of NPS
Pharmaceuticals stock they own. The claims concern whether the
Board of NPS Pharmaceuticals breached their fiduciary duties to
stockholders by failing to adequately shop the Company before
agreeing to enter into this transaction, and whether Shire plc is
underpaying for NPS Pharmaceuticals shares.
If you own NPS Pharmaceuticals common stock and wish to obtain
additional information, please contact Joseph E. Levi, Esq. either
via email at jlevi@zlk.com or by telephone at (212) 363-7500,
toll-free: (877) 363-5972, or visit
http://zlk.9nl.com/nps-pharmaceuticals-npsp.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, Connecticut and Washington D.C. The firm's
attorneys have extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors
throughout the nation in securities and shareholder lawsuits. For
more information, please feel free to contact any of the attorneys
listed below. Attorney advertising. Prior results do not guarantee
similar outcomes.
CONTACT: Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510
www.zlk.com
Nps (NASDAQ:NPSP)
Gráfica de Acción Histórica
De Sep 2024 a Oct 2024
Nps (NASDAQ:NPSP)
Gráfica de Acción Histórica
De Oct 2023 a Oct 2024
Real-Time news about (MM) (NASDAQ): 0 recent articles
Más de Artículos de Noticias